Cutaneous T-cell lymphomas: modern data of pathogenesis, clinics and therapy
Cutaneous T-cell lymphomas (CTCL) are a heterogeneous group of extranodal non-Hodgkin’s lymphomas that are characterized by skin infiltration with malignant monoclonal T lymphocytes. More common in adults aged 55 to 60 years, the annual incidence is about 0.5 per 100 000 people. Mycosis fungoides, S...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2018-10-01
|
Series: | Onkogematologiâ |
Subjects: | |
Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/304 |
id |
doaj-9f5a93acf09c4b929a312405a2c49315 |
---|---|
record_format |
Article |
spelling |
doaj-9f5a93acf09c4b929a312405a2c493152021-07-29T09:03:06ZrusABV-pressOnkogematologiâ1818-83462018-10-01133253810.17650/1818-8346-2018-13-3-25-38277Cutaneous T-cell lymphomas: modern data of pathogenesis, clinics and therapyO. M. Demina0O. E. Akilov1A. G. Rumyantsev2Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia.University of Pittsburgh, Department of Dermatology, Cutaneous Lymphoma Clinics.Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia.Cutaneous T-cell lymphomas (CTCL) are a heterogeneous group of extranodal non-Hodgkin’s lymphomas that are characterized by skin infiltration with malignant monoclonal T lymphocytes. More common in adults aged 55 to 60 years, the annual incidence is about 0.5 per 100 000 people. Mycosis fungoides, Sézary syndrome and CD30+ lymphoproliferative diseases are the main subtypes of CTCL. To date, CTCL have a complex concept of etiopathogenesis, diagnosis, therapy and prognosis. The article presented summary data on these issues.https://oncohematology.abvpress.ru/ongm/article/view/3041cutaneous t-cell lymphomasgene expressionanticancer treatment |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
O. M. Demina O. E. Akilov A. G. Rumyantsev |
spellingShingle |
O. M. Demina O. E. Akilov A. G. Rumyantsev Cutaneous T-cell lymphomas: modern data of pathogenesis, clinics and therapy Onkogematologiâ 1cutaneous t-cell lymphomas gene expression anticancer treatment |
author_facet |
O. M. Demina O. E. Akilov A. G. Rumyantsev |
author_sort |
O. M. Demina |
title |
Cutaneous T-cell lymphomas: modern data of pathogenesis, clinics and therapy |
title_short |
Cutaneous T-cell lymphomas: modern data of pathogenesis, clinics and therapy |
title_full |
Cutaneous T-cell lymphomas: modern data of pathogenesis, clinics and therapy |
title_fullStr |
Cutaneous T-cell lymphomas: modern data of pathogenesis, clinics and therapy |
title_full_unstemmed |
Cutaneous T-cell lymphomas: modern data of pathogenesis, clinics and therapy |
title_sort |
cutaneous t-cell lymphomas: modern data of pathogenesis, clinics and therapy |
publisher |
ABV-press |
series |
Onkogematologiâ |
issn |
1818-8346 |
publishDate |
2018-10-01 |
description |
Cutaneous T-cell lymphomas (CTCL) are a heterogeneous group of extranodal non-Hodgkin’s lymphomas that are characterized by skin infiltration with malignant monoclonal T lymphocytes. More common in adults aged 55 to 60 years, the annual incidence is about 0.5 per 100 000 people. Mycosis fungoides, Sézary syndrome and CD30+ lymphoproliferative diseases are the main subtypes of CTCL. To date, CTCL have a complex concept of etiopathogenesis, diagnosis, therapy and prognosis. The article presented summary data on these issues. |
topic |
1cutaneous t-cell lymphomas gene expression anticancer treatment |
url |
https://oncohematology.abvpress.ru/ongm/article/view/304 |
work_keys_str_mv |
AT omdemina cutaneoustcelllymphomasmoderndataofpathogenesisclinicsandtherapy AT oeakilov cutaneoustcelllymphomasmoderndataofpathogenesisclinicsandtherapy AT agrumyantsev cutaneoustcelllymphomasmoderndataofpathogenesisclinicsandtherapy |
_version_ |
1721249547347296256 |